Covidien Surgical Stapler Lawsuit Blames Defective Design for Botched Hernia Repair and Gastric Sleeve Surgery
Surgical Stapler Lawsuit Claims Device Failure Led To Anastomotic Leak, Repeated Surgeries and Ostomy Pouch
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Ethicon Circular Stapler Recall Issued Over Insufficient Firing Events, Injury Risks May 17, 2019 Irvin Jackson Add Your Comments As federal regulators continues a campaign to improve the safety of surgical staplers, Ethicon has recalled nearly 100,000 devices, due to problems with the firing sequence, which could result in serious patient injuries or deaths. The FDA announced an Ethicon Endo-Surgery Stapler recall on May 16, warning that the device has been linked to reports of insufficient firing, which can result in circular staples failing. Ethicon has received at least two reports of serious injuries to patients, and the FDA has classified this as a Class I recall, the most serious classification, and an indication that problems with the staplers can result in patient injury or death. Learn More About Surgery Staples Lawsuits Problems with surgical staplers may result in devastating injuries from internal surgery staples. Lawyers review cases nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Surgery Staples Lawsuits Problems with surgical staplers may result in devastating injuries from internal surgery staples. Lawyers review cases nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The affected staplers are used for creating connections between structures in the gastrointestinal tract during surgical procedures. In both of the reported injuries, patients had to undergo a surgical resection of parts of their rectum due to staple failures. “Through investigation of complaints and returned products, Ethicon confirmed uncut washers in the stapler and malformed staples occur with their intraluminal circular staplers due to insufficient firing, which can compromise staple line integrity,” the recall notice warns. “When the washer is cut, confirming completion of the firing cycle, the surgeon experiences an audible and tactile crunch. Failure to cut the washer suggests complete 360-degree staple line failure.” Manufacturing of the affected staples was halted in March after problems were discovered in the production process, the FDA reports. The recall impacts the Endo-Surgery Curved Intraluminal Stapler with Adjustable Height Staples, and the Endo-Surgery Endoscopic Curved Intraluminal Stapler with Adjustable Height Staples. They were sold under product codes CDH21A, CDH25A, CDH29A, CDH33A, ECS21A, ECS25A, ECS29A, and ECS33A. The product codes are located on the front of the single unit cartons. The recall includes 92,496 devices in the United States. Which were manufactured between March 6, 2018 and March 6, 2019, and were distributed from March 15, 2018 to March 8, 2019. FDA Surgical Stapler Concerns Last month, the FDA proposed new rules and guidelines designed to make surgical staplers safer, and to classify them as moderate risk medical devices. They are currently classified as low-risk devices. The new classification would require more stringent premarket approval for new staplers and force manufacturers to provide more thorough safety warnings and instructions. The most commonly reported surgical stapler problems involve an opening of the staple line, malformation of staples, staplers misfiring, staplers being too difficult to fire, staplers failing to fire and staplers that were misapplied. The FDA warning indicates that stapler malfunctions or misuse can cause prolonged surgical procedures, the need for additional surgeries, and other complications; such as bleeding, sepsis, internal organ damage, and death. In 2012, Ethicon had to recall more than 150,000 of its Endo-Surgical circular staplers due to similar problems. The Ethicon surgical stapler recall came after surgeons began abandoning use of the devices during surgical procedures because they had so many problems firing them. Three years later, in 2015, a California jury awarded nearly $80 million to a retired San Jose police officer whose anal canal was accidentally sealed by a defective Ethicon surgical stapler. The FDA indicates Ethicon notified affected customers of this most recent recall last month, and provided instructions to health care facilities, distributors and other customers on what to do with the staplers. The instructions called for them to quarantine any affected products, remove it from use or distribution, and to communicate with relevant operating room or materials management personnel, or anyone who may use the staplers. Ethicon also provided instructions on how to return those affected by the recall and to receive replacement products. Those affected staplers must be returned by June 30, 2019 in order to receive a replacement. Customers returning recalled staplers can contact Stericycle at 1-888-671-8832 and reference Event #5011. Those with additional questions can contact Ethicon Customer Support Center at 1-877-384-4266. Anyone who has experienced a problem with the staplers is encouraged to report the incident to the FDA’s MedWatch adverse event reporting program. Tags: Ethicon, Johnson & Johnson, Medical Device Recall, Surgical Stapler More Surgical Staplers Lawsuit Stories Covidien Stapler Malfunctioned During Surgery, Leading to Tissue Damage and Hospitalization: Lawsuit September 13, 2022 Covidien Surgical Stapler Lawsuit Blames Defective Design for Botched Hernia Repair and Gastric Sleeve Surgery June 9, 2022 Surgical Stapler Lawsuit Claims Device Failure Led To Anastomotic Leak, Repeated Surgeries and Ostomy Pouch February 18, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (Posted: 2 days ago) A West Virginia woman’s lawsuit over complications with a Cartiva implant has been scheduled to go before a jury in February 2026, involving claims that the big toe implant failed just weeks before the manufacturer issued a Cartiva recall. MORE ABOUT: CARTIVA IMPLANT LAWSUITLawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)Cartiva Implant Failure Symptoms Reported By Big Toe Surgery Patients in Lawsuits, Social Media and FDA Adverse Events (12/26/2024) Lawsuits Over Social Media Addiction Injuries Cleared To Move Forward in MDL (Posted: 3 days ago) A federal judge has rejected a motion to dismiss claims involving wrongful death and negligence raised in lawsuits over social media addiction brought by families throughout the U.S. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITGambling Addiction Lawsuit Filed Against Sports Betting Platform DraftKings (02/20/2025)Facebook, TikTok Named in Social Media Addiction Lawsuit Brought by Native American Tribe Over Harm to Youth (01/13/2025)Online Gaming Addiction Lawsuit Alleges Roblox, Epic Games Intentionally Targeted Minors (12/20/2024) BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (Posted: 4 days ago) A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker. MORE ABOUT: BIOZORB LAWSUITSchedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)Joint BioZorb Marker Lawsuit Claims Implant Caused Seroma, Infections and Other Complications (02/04/2025)
Covidien Stapler Malfunctioned During Surgery, Leading to Tissue Damage and Hospitalization: Lawsuit September 13, 2022
Covidien Surgical Stapler Lawsuit Blames Defective Design for Botched Hernia Repair and Gastric Sleeve Surgery June 9, 2022
Surgical Stapler Lawsuit Claims Device Failure Led To Anastomotic Leak, Repeated Surgeries and Ostomy Pouch February 18, 2022
Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (Posted: 2 days ago) A West Virginia woman’s lawsuit over complications with a Cartiva implant has been scheduled to go before a jury in February 2026, involving claims that the big toe implant failed just weeks before the manufacturer issued a Cartiva recall. MORE ABOUT: CARTIVA IMPLANT LAWSUITLawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)Cartiva Implant Failure Symptoms Reported By Big Toe Surgery Patients in Lawsuits, Social Media and FDA Adverse Events (12/26/2024)
Lawsuits Over Social Media Addiction Injuries Cleared To Move Forward in MDL (Posted: 3 days ago) A federal judge has rejected a motion to dismiss claims involving wrongful death and negligence raised in lawsuits over social media addiction brought by families throughout the U.S. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITGambling Addiction Lawsuit Filed Against Sports Betting Platform DraftKings (02/20/2025)Facebook, TikTok Named in Social Media Addiction Lawsuit Brought by Native American Tribe Over Harm to Youth (01/13/2025)Online Gaming Addiction Lawsuit Alleges Roblox, Epic Games Intentionally Targeted Minors (12/20/2024)
BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (Posted: 4 days ago) A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker. MORE ABOUT: BIOZORB LAWSUITSchedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)Joint BioZorb Marker Lawsuit Claims Implant Caused Seroma, Infections and Other Complications (02/04/2025)